Pharmaceutical IT Spending Market Overview in Italy to 2013

• Publication date: March 2009

About This Report This databook provides a projection and analysis of IT spending in the pharma/biotech markets through to 2013 in Italy. The segments covered include big pharma, mid pharma, biotech, and small pharma/biotech. What's In This Report *The databook provides projections relating to total pharmaceutical IT spending in Italy through to 2013 *In each sub-sector, pharmaceutical IT spending is se...

About This Report

This databook provides a projection and analysis of IT spending in the pharma/biotech markets through to 2013 in Italy. The segments covered include big pharma, mid pharma, biotech, and small pharma/biotech.

What's In This Report

*The databook provides projections relating to total pharmaceutical IT spending in Italy through to 2013

*In each sub-sector, pharmaceutical IT spending is sector ed by hardware, software and services

*Contains pharmaceutical IT spending projections in Italy in relation to the wider region

Key Market Facts

The big pharma segment led the pharmaceutical IT spending in Italy accounting for 54.8% of the total IT spending in 2007.

Pharmaceutical IT spending in Italy is expected to increase at a growth rate (CAGR) of 4.2% over the 2008-13 period.

Italy accounted for 10.3% of the total pharmaceutical IT spending in Europe in 2007.

Why Should You Buy This Report?

*Understand the opportunity for technology spending in the life science industry

*Identify potential areas for spending growth amongst pharmaceutical and biotechnology firms

*Contains an analysis of pharmaceutical IT spending projection by each segment in Italy

Pharmaceutical Industry in Italy

TABLE OF CONTENTS
OVERVIEW 1
Catalyst 1
Summary 1
INTRODUCTION 5
Reasons to purchase 5
PHARMACEUTICAL IT SPENDING 6
Pharmaceutical IT spending projection in Italy to 2013 6
PHARMACEUTICAL IT SPENDING IN Euros OPE and Italy 9
Comparison of Pharmaceutical IT spending in Italy and EUR pe to 2013 9
Pharmaceutical IT spending in EUR pe by segment 2013 10
PHARMACEUTICAL IT SPENDING BY SECTOR 12
Big pharma segment projection 12
Mid pharma segment projection 14
Biotech segment projection 16
Small pharma/biotech projection 18
APPENDIX 20
Further reading 20
How to contact experts in your market 20
Disclaimer 20


Index of Figures
Chart 1: Pharmaceutical IT spending in Italy, 2007–2013 ($m) 6
Chart 2: Pharmaceutical IT spending in EUR pe and Italy, 2007–2013 ($m) 9
Chart 3: Pharmaceutical IT spending in EUR pe, 2007–2013 (%) 10
Chart 4: IT spending in the big pharma segment in Italy, 2007–2013 (%) 12
Chart 5: IT spending in the mid pharma segment in Italy, 2007–2013 (%) 14
Chart 6: IT spending in the biotech segment in Italy, 2007–2013 (%) 16
Chart 7: IT spending in the small pharma/biotech segment in Italy, 2007–2013 (%) 18


Index of Tables
Data table 1: Pharmaceutical IT spending data specifications: 5
Data table 2: Pharmaceutical IT spending in Italy, 2007–2013 ($m) 7
Data table 3: Pharmaceutical IT spending in Italy, 2007–2013 (%) 8
Data table 4: Pharmaceutical IT spending in EUR pe and Italy, 2007–2013 ($m) 9
Data table 5: Pharmaceutical IT spending in EUR pe, 2007–2013 ($m) 11
Data table 6: IT spending in the big pharma segment in Italy, 2007–2013 ($m) 13
Data table 7: IT spending in the mid pharma segment in Italy, 2007–2013 ($m) 15
Data table 8: IT spending in the biotech segment in Italy, 2007–2013 ($m) 17
Data table 9: IT spending in the small pharma/biotech segment in Italy, 2007–2013 ($m) 19

Pharmaceutical in Italy

Italy Poisonings, 70+ Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pharmaceutical
• Countries : Italy

Italy Poisonings, 30-44 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pharmaceutical
• Countries : Italy

Italy Poisonings, Total, Female, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pharmaceutical
• Countries : Italy

Italy Poisonings, 60-69 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pharmaceutical
• Countries : Italy

Italy Poisonings, 30-44 Yrs, Female, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pharmaceutical
• Countries : Italy